Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial.

Published in: Clinical journal of the American Society of Nephrology : CJASN (2021)

Belatacept Early Steroid Withdrawal Trial, NCT01729494.

Keyphrases